Suppr超能文献

基于国家生存结局数据的结肠癌改良 TN 分类。

Revised TN categorization for colon cancer based on national survival outcomes data.

机构信息

Mayo Clinic Cancer Center-Scottsdale, Radiation Oncology, 13400 East Shea Blvd, Scottsdale, AZ 85259, USA.

出版信息

J Clin Oncol. 2010 Jan 10;28(2):264-71. doi: 10.1200/JCO.2009.24.0952. Epub 2009 Nov 30.

Abstract

PURPOSE

The sixth edition of American Joint Committee on Cancer (AJCC) Cancer Staging Manual for colon cancer subdivided stage II into IIA (T3N0) and IIB (T4N0) and stage III into IIIA (T1-2N1M0), IIIB (T3-4N1M0), and IIIC (anyTN2M0). Subsequent analyses supported revised substaging of stage III because of improved survival for T1-2N2 versus T3-4N2 and T4N1 survival was more similar to T3-4N2 than to T3N1. The AJCC Hindgut Taskforce sought population-based validation that depth of invasion and nodal status interact to affect survival.

PATIENTS AND METHODS

Surveillance, Epidemiology, and End Results (SEER) population-based data from January 1992 to December 2004 for 109,953 colon cancer patients were compared with National Cancer Data Base (NCDB) data on 134,206 patients. T4N0 cancers were stratified by tumors that perforate visceral peritoneum (T4a) versus tumors that invade or are adherent to adjacent organs or structures (T4b). N1 and N2 were stratified by number of involved positive lymph nodes (N+): N1a/N1b (1 v 2-3), N2a/N2b (4 to 6 v > or = 7). Five-year observed and relative survival data were obtained for each TN category.

RESULTS

SEER rectal cancer analyses confirm that T1-2N2 cancers have better prognosis than T3-4N2,T4bN1 have similar prognosis to T4N2, T1-2N1 have similar prognosis to T2N0/T3N0, and T1-2N2ahave similar prognosis to T2N0/T3N0 (T1N2a) or T4aN0 (T2N2a). Prognosis for T4a lesions is betterthan T4b by N category. The number of positive nodes affects prognosis.

CONCLUSION

This SEER population-based colon cancer analysis is highly consistent with rectal cancer pooled analysis and SEER rectal cancer analyses, supporting the shift of T1-2N2 lesions from IIIC to IIIA/IIIB, shifting T4bN1 from IIIB to IIIC, subdividing T4/N1/N2, and revising substaging of stages II/III. Survival outcomes by TN category for colon and rectal cancer are strikingly similar.

摘要

目的

第六版美国癌症联合委员会(AJCC)结直肠癌分期手册将 II 期细分为 IIA(T3N0)和 IIB(T4N0),III 期细分为 IIIA(T1-2N1M0)、IIIB(T3-4N1M0)和 IIIC(任何 T 任何 N2M0)。随后的分析支持对 III 期进行修订亚分期,因为 T1-2N2 的生存率优于 T3-4N2,而 T4N1 的生存率与 T3-4N2 更相似,而不是 T3N1。AJCC 肠内肿瘤工作组寻求基于人群的验证,即浸润深度和淋巴结状态相互作用影响生存。

方法

比较 1992 年 1 月至 2004 年 12 月的监测、流行病学和最终结果(SEER)人群数据与 134,206 名患者的国家癌症数据库(NCDB)数据。T4N0 癌症分为穿透内脏腹膜的肿瘤(T4a)与侵犯或粘附于相邻器官或结构的肿瘤(T4b)。N1 和 N2 分为阳性淋巴结受累数(N+):N1a/N1b(1 对 2-3),N2a/N2b(4 对 6 对 ≥7)。每个 TN 类别均获得五年观察和相对生存率数据。

结果

SEER 直肠癌分析证实,T1-2N2 癌症的预后优于 T3-4N2,T4bN1 的预后与 T4N2 相似,T1-2N1 的预后与 T2N0/T3N0 相似,T1-2N2ah 的预后与 T2N0/T3N0(T1N2a)或 T4aN0(T2N2a)相似。N 类中 T4a 病变的预后优于 T4b。阳性淋巴结数影响预后。

结论

这项基于 SEER 的结肠癌分析与直肠癌汇总分析和 SEER 直肠癌分析高度一致,支持将 T1-2N2 病变从 IIIIC 转移到 IIIA/IIIB,将 T4bN1 从 IIIB 转移到 IIIC,细分 T4/N1/N2,并修订 II/III 期的亚分期。结直肠癌的 TN 分类的生存结果非常相似。

相似文献

引用本文的文献

9
Adoptive immune cell therapy for colorectal cancer.结直肠癌的过继性免疫细胞疗法。
Front Immunol. 2025 Apr 1;16:1557906. doi: 10.3389/fimmu.2025.1557906. eCollection 2025.

本文引用的文献

5
The staging of colorectal cancer: 2004 and beyond.结直肠癌的分期:2004年及以后。
CA Cancer J Clin. 2004 Nov-Dec;54(6):295-308. doi: 10.3322/canjclin.54.6.295.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验